Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT05177354
Registration number
NCT05177354
Ethics application status
Date submitted
30/11/2021
Date registered
4/01/2022
Date last updated
22/04/2024
Titles & IDs
Public title
Medtronic Closed-Loop Spinal Cord Stimulation System
Query!
Scientific title
Evaluation of Long-term Patient Experience With a Medtronic Closed-Loop Spinal Cord Stimulation System
Query!
Secondary ID [1]
0
0
MDT21017
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Low Back Pain
0
0
Query!
Leg Pain
0
0
Query!
Upper Limb Pain
0
0
Query!
Condition category
Condition code
Musculoskeletal
0
0
0
0
Query!
Other muscular and skeletal disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Devices - Inceptiv
Experimental: Treatment -
Treatment: Devices: Inceptiv
Implantable Neurostimulator with Neuro Sense
Query!
Intervention code [1]
0
0
Treatment: Devices
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Reduction in overstimulation sensation
Query!
Assessment method [1]
0
0
Comparison of Neuro Sense On vs Off at in-clinic testing for low-back and/or leg pain subjects. Subjects will perform protocol prescribed activities and rate the intensity of the sensation on a 5-point Likert scale. The average intensity scores during each period will be calculated for each subject. The proportion of low-back and leg pain subjects with a reduction in overstimulation sensation during Neuro Sense On compared to Neuro Sense Off will be calculated, with a one-sided 97.5% lower bound.
Query!
Timepoint [1]
0
0
30 days from device activation
Query!
Secondary outcome [1]
0
0
Responder rate for treatment of overall pain
Query!
Assessment method [1]
0
0
Low-back and/or leg pain subjects
Query!
Timepoint [1]
0
0
3 months from device activation
Query!
Secondary outcome [2]
0
0
Responder rate for treatment of low-back pain
Query!
Assessment method [2]
0
0
Low-back pain subjects (baseline back VAS =60mm)
Query!
Timepoint [2]
0
0
3 months from device activation
Query!
Secondary outcome [3]
0
0
Responder rate for treatment of leg pain
Query!
Assessment method [3]
0
0
Leg pain subjects (baseline leg VAS =60mm)
Query!
Timepoint [3]
0
0
3 months from device activation
Query!
Eligibility
Key inclusion criteria
- 18 years of age or older
- Candidate is undergoing Medtronic SCS device trial for chronic, intractable pain of
the trunk and/or limbs
- If being treated for low-back and/or leg pain,
- the baseline overall^ Visual Analog Scale is = 60 mm and
- baseline back and/or leg pain Visual Analog Scale is =60 mm. ^Average overall
pain in the back and/or leg in the 72 hours prior to the baseline visit, measured
using Visual Analog Scale.
- If being treated for upper limb pain - baseline Visual Analog Scale is = 60 mm for
upper limb pain
- On stable (no change in dose, route, or frequency) prescribed pain medications being
used for back and leg pain or upper limb pain, as determined by the investigator, for
at least 28 days prior to device trial
- Willing and able to provide signed and dated informed consent
- Willing and able to comply with all study procedures and visits
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
- Indicated for an SCS device to treat stable intractable Angina Pectoris or Peripheral
Vascular Disease of Fontaine Stage III or higher
- Previously trialed or implanted with spinal cord stimulator, peripheral or vagus nerve
stimulator, deep brain stimulator or an implantable intrathecal drug delivery system
- Currently participating, or plans to participate, in another investigational study
unless written approval is provided by the Medtronic study team
- Major psychiatric comorbidity or other progressive diseases that may confound study
results, as determined by the Investigator
- Serious drug-related behavioral issues (e.g. alcohol dependency, illegal substance
abuse), as determined by the Investigator
- Pregnant or planning on becoming pregnant (if female and sexually active, subject must
be using a reliable form of birth control, be surgically sterile, or be at least 2
years post-menopausal)
- Be involved in an injury claim or under current litigation
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
N/A
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Single group
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Active, not recruiting
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
30/11/2021
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
31/08/2025
Query!
Actual
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
94
Query!
Recruitment in Australia
Recruitment state(s)
NSW,QLD,VIC
Query!
Recruitment hospital [1]
0
0
Sydney Pain Specialists - Bella Vista
Query!
Recruitment hospital [2]
0
0
Genesis Research Services - Broadmeadow
Query!
Recruitment hospital [3]
0
0
Australian Medical Research - Hurstville
Query!
Recruitment hospital [4]
0
0
Royal North Shore Hospital - Saint Leonards
Query!
Recruitment hospital [5]
0
0
Sydney Pain Research Centre - Wahroonga
Query!
Recruitment hospital [6]
0
0
Sunshine Coast Clinical Research - Noosa Heads
Query!
Recruitment hospital [7]
0
0
Precision Brain Spine and Pain Center - Kew
Query!
Recruitment postcode(s) [1]
0
0
2153 - Bella Vista
Query!
Recruitment postcode(s) [2]
0
0
2292 - Broadmeadow
Query!
Recruitment postcode(s) [3]
0
0
2220 - Hurstville
Query!
Recruitment postcode(s) [4]
0
0
2065 - Saint Leonards
Query!
Recruitment postcode(s) [5]
0
0
2076 - Wahroonga
Query!
Recruitment postcode(s) [6]
0
0
4567 - Noosa Heads
Query!
Recruitment postcode(s) [7]
0
0
3101 - Kew
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Query!
Name
MedtronicNeuro
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The purpose of the study is to further understand the closed-loop feature in chronically
implanted patients by characterizing the efficacy of the next generation, spinal cord
stimulator.
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT05177354
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Marc Russo, MD
Query!
Address
0
0
Genesis Research Services
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT05177354
Download to PDF